title: Retinitis preceding systemic lupus erythematosus in absence of anti-phospholipid antibodies.
authors.forename: Mario
authors.initials: M
authors.lastname: Rodenas
authors.forename: Santhosh
authors.initials: S
authors.lastname: Kumar
authors.forename: Kenneth Bailey
authors.initials: KB
authors.lastname: Freund
authors.forename: Jack
authors.initials: J
authors.lastname: Moallem
mesh_terms: D000293:Adolescent; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D001262:Atenolol / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D008775:Methylprednisolone / Q000008:administration & dosage; D009543:Nifedipine / Q000627:therapeutic use; D020551:Pulse Therapy, Drug; D051437:Renal Insufficiency; D012173:Retinitis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D016896:Treatment Outcome; D014786:Vision Disorders
chemical_list: D017152:Antibodies, Antiphospholipid; D001262:Atenolol; D003520:Cyclophosphamide; D009543:Nifedipine; D008775:Methylprednisolone